Skip to content

Hospital Medicine Virtual Journal Club

Menu

Search for:

About
Archives
FAQs
How to Access Full-text Articles
How to Use
Privacy Policy and Terms of Use

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.

JAMA • May 12, 2020

Link to article at PubMed

Related Articles

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.

JAMA. 2020 May 11;:

Authors: Kirkcaldy RD, King BA, Brooks JT

PMID: 32391855 [PubMed - as supplied by publisher]

Share this:

Click to share on Facebook (Opens in new window)
Click to share on Twitter (Opens in new window)
Click to share on LinkedIn (Opens in new window)
Click to share on Reddit (Opens in new window)
Click to email this to a friend (Opens in new window)
Click to print (Opens in new window)

Leave a Reply

Your email address will not be published.

Comment

Name

Email

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Follow Us!

Journal Club via Email

Sign up for Email updates!

The HMVJC Minute Podcast

	
	
		

Subscribe Now!


	Anchor
Apple Podcasts
Breaker
Google Podcasts
iHeartRadio
PocketCasts
Podbay
Radio Public
Spotify
TikTok
YouTube

Recent Comments

agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial
Anonymous on What is the role of remdesivir in patients with COVID-19?

The HMVJC COVID Reading List

Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial
Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes – a case series from Lahore, Pakistan
Death among patients hospitalized with symptomatic COVID-19: Implications for high-risk patients
Wellness of hospitalists and hospital medicine advanced practice providers during the COVID-19 pandemic, 2020-2021
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID-19 patients
Teaching Evidence-Based Physical Diagnosis: A Workshop for Hospitalists
Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial
In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study

Links

WU School of Medicine
Dept. of Medicine
Division of Hospital Medicine
Becker Medical Library
Society of Hospital Medicine
Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis

Send to Email Address Your Name Your Email Address

Cancel

Post was not sent - check your email addresses!

Email check failed, please try again

Sorry, your blog cannot share posts by email.